Antitrust Enforcement Update: Spotlight on Physician Transactions

McDermott Will & Emery

At both the state and federal level, antitrust enforcement agencies continue to pursue successful challenges to physician practice transactions. This article summarizes two recent enforcement actions, as well as a new state law that requires prior notice of healthcare provider transactions. We also offer practical takeaways for providers pursuing practice acquisitions.


Last week, the Eighth Circuit Court of Appeals upheld the grant of a preliminary injunction barring a health system’s attempted acquisition of a multi-specialty practice in North Dakota, and last month, the Washington Attorney General settled a challenge to a health system’s acquisition of physician practices. Washington state also passed a law that will require prior notice of transactions involving seven or more health care providers. Health care providers should engage in careful planning for antitrust enforcement agency review of provider transactions of all sizes.

Key Takeaways

Structure of Transaction: The Washington Attorney General challenged the structure of one of the physician practice acquisitions—a professional services agreement for physician services in connection with the sale of practice assets—a not uncommon physician transaction structure. The Washington Attorney General alleged that post-closing, the parties remained competitors under the antitrust laws, and that their joint contracting with payors was per se unlawful under the antitrust laws. It remains to be seen whether any other state attorneys general or the federal antitrust enforcement agencies take a like stance when presented with similar facts. Health care providers, however, should be mindful of the position that the Washington Attorney General took in this case when determining the structure of their provider transactions, particularly those where the physician practice target entity remains in existence under separate ownership post-closing.

Size of Transaction: As these enforcement actions demonstrate, providers should not assume that transactions involving physician practices are too small to garner antitrust scrutiny from federal and state antitrust enforcers. Parties to transactions should engage in careful antitrust review, including analyzing potential transactions with physician practices on a specialty-by-specialty basis. Parties should also be prepared to explain how a proposed merger or acquisition with a physician practice will lead to lower costs, higher quality or greater access to services.

State Reporting Requirements: Providers should monitor state reporting requirements. Washington state’s new legislation requires prior notification of health care provider transactions involving as few as seven health care providers. It remains to be seen whether other states will follow suit, although Florida recently considered a similar bill, Florida HB 1243, which would have required notice of health provider transactions involving as few as four providers (although the bill passed the state house, the legislative session ended without the state senate taking any action on the bill).

Sanford Health/Mid-Dakota Clinic

On June 13, 2019, the Eight Circuit Court of Appeals upheld the district court’s grant of a preliminary injunction barring Sanford Health’s acquisition of Mid-Dakota Clinic (MDC) in Bismarck and Mandan, North Dakota, pending an administrative trial on the merits. The appeals court found that there was no legal error by the district court.

The Federal Trade Commission (FTC) and the North Dakota Attorney General (ND AG) sued in June 2017 to block the acquisition. The FTC also filed an administrative complaint challenging the transaction. In December 2017, a federal district court preliminarily enjoined the acquisition. The court concluded that the FTC showed a likelihood of ultimate success on the merits that the merger violates Section 7 of the Clayton Act, 15 U.S.C. § 18.

In the Bismarck and Mandan areas, Sanford Health operates a general acute care hospital and clinics consisting of approximately 160 physicians. MDC is a multispecialty medical practice employing 61 physicians who provide services in Bismarck.

The FTC challenged the combination of providers in four physician specialty markets: adult primary care, pediatric, obstetrics/gynecology (OB/GYN) and general surgery. The district court cited the testimony of the FTC’s expert witness and previous cases to determine that the relevant product markets must be defined by specialty. The three primary commercial insurers—Blue Cross Blue Shield of North Dakota (BCBSND), Sanford Health Plan and Medica—also testified that insurance networks must include each distinct specialty to be marketable as a successful health plan. The district court agreed with the FTC that the relevant geographic market encompassed four North Dakota counties, collectively called the “Bismarck-Mandan” area.

The district court examined the increase in market shares and market concentration, and found that the four physician markets in the Bismarck-Mandan area were already highly concentrated and would be even more so post-transaction. The FTC and Department of Justice (DOJ) Horizontal Merger Guidelines define a highly concentrated market as one with a Herfindahl-Hirschman Index (HHI), a market concentration measure, of more than 2,500. The HHI evidence showed post-merger HHIs ranging from 7,363 to 9,964 in the four physician services markets. Under the FTC/DOJ Horizontal Merger Guidelines, the FTC and DOJ presume that mergers resulting in highly concentrated markets that involve an increase in the HHI of more than 200 points are likely to enhance market power.

In its analysis of the competitive effects of the transaction, the district court relied on testimony predicting pricing effects, diversions, upward-pricing pressure (UPP) and a willingness to pay analysis (WTP). The lower court began its competitive analysis by crediting hearing testimony that “each of the two entities views the other as its primary competitor.” The lower court then explained that the diversion ratio indicates the percentage of patients who would switch to another provider if theirs was no longer available. The FTC’s expert testified that this ratio, performed in the Bismarck-Mandan area, demonstrated that patients at Sanford and MDC view the other as their “next best option.” Next, the lower court described UPP as the incentive to increase prices post-transaction. The FTC’s expert found a UPP of 6–22%, equating to $16–27 million dollars annually. Finally, the lower court explained that the WTP analysis demonstrated that there were no other close substitute providers in the four physician markets.

The district court then concluded that the proposed transaction was “presumptively unlawful” for each physician specialty market. The appeals court found that this determination was supported by the empirical analysis of claims data and payor testimony.

The district court considered various defenses by Sanford and MDC, including the argument that BCBSND is a dominant buyer that sets reimbursement rates using a statewide, rather than an individually negotiated, pricing schedule. Relying on testimony that BCBSND expects an immediate increase in Sanford’s bargaining leverage if the transaction is consummated, the district court rejected the power buyer argument. The appeals court found that the district court properly found a relationship between market concentration after the merger and increased bargaining leverage.

The district court had also rejected as inadequate the argument that a private agreement between Sanford and Medica would prevent price increases, and arguments of entry or expansion in the market, especially those that another area health system and its acute care hospital could recruit enough physicians to balance the anticompetitive effects of the transaction. Finally, the court rejected defendants’ arguments that MDC was a “weakened competitor,” concluding that there was no indication that MDC would “imminently depart” the market if the merger failed. The appeals court found that the district court’s findings were not clear error.

CHI Franciscan Health/The Doctor’s Clinic

On May 13, 2019, the Washington Attorney General announced a consent decree with CHI Franciscan to resolve an antitrust complaint challenging two physician practice acquisitions in the Kitsap Peninsula immediately west of Seattle. Under the terms of the consent decree, CHI Franciscan will pay two million dollars and divest a controlling interest in an outpatient surgery center.

In July 2016, CHI Franciscan acquired WestSound Orthopaedics, PS (WSO), an orthopedic practice of seven physicians located in Silverdale, Washington, and in September 2016, CHI Franciscan executed several agreements with The Doctors Clinic (TDC), a 54-physician multi-specialty practice in Silverdale, Washington. The Washington Attorney General alleged that the transactions violated Section 1 of the Sherman Act, Section 7 of the Clayton Act, and two provisions of Washington’s Consumer Protection Act.

CHI Franciscan and TDC entered into three primary agreements—a professional services agreement, a management services agreement and an asset purchase agreement. Under the professional services agreement, the TDC physicians remain employees of TDC, but provide services exclusively on behalf of CHI Franciscan. CHI Franciscan bills for services rendered by TDC physicians under CHI Franciscan’s name, tax identification number and payor contracts. CHI Franciscan is entitled to retain all compensation received from payors for TDC physician services and compensates TDC physicians on a productivity-based model. The state alleged that this conduct constituted per se unlawful price-fixing in violation of Section 1 of the Sherman Act. The state argued that CHI Franciscan and TDC remained separate economic entities with no overlapping ownership or boards. The state also noted that the parties maintained their own electronic health record systems, and carried out their own back office functions and day-to-day operations.

The complaint alleged that CHI Franciscan and TDC have a combined market share of over 50% for adult primary care services and a combined market share of over 63% for orthopedic physician services in a geographic area no broader than the Kitsap Peninsula. The complaint alleges that as a result of the Westsound acquisition, the post-transaction HHI is at least 3,591 (with an increase of 2,222) in the orthopedic physician services market and, as a result, is presumptively unlawful.

CHI Franciscan and TDC moved to dismiss the state’s claims on the grounds that the state misconstrued the affiliation agreements. The court, however, denied the motion to dismiss. The court subsequently denied summary judgment for the defendants regarding the state’s ability to challenge the affiliation agreements as per se illegal under Section 1 of the Sherman Act. The defendants argued that the affiliation was not automatically illegal because, absent the affiliation, TDC would have gone out of business. The court rejected this argument and found that the competitive loss of a market participant was not a defense to an otherwise illegal price-fixing agreement.

Following the district court’s denial of the defendants’ motion for summary judgment, the defendants entered into a settlement with the state. WSO joined the settlement for purposes of the release of claims and is not bound by the injunction or reporting provisions. Under the terms of the proposed consent decree:

  • Future Contract Prohibitions: For a period of seven years, CHI Franciscan and TDC cannot negotiate with any commercial payor on behalf of any unemployed physician for which the defendants already employ physicians in the same specialty. The defendants also are prohibited from facilitating the exchange of information among employed and non-employed physicians concerning price or other payor contract terms.
  • Notice Provisions for Certain Transactions and Arrangements: CHI Franciscan and TDC also agreed to provide 60 days’ advance written notice to the state attorney general before entering into an arrangement with seven or more unemployed physicians who practice at facilities within 15 miles of where CHI Franciscan-employed physicians in the same specialty already practice. CHI Franciscan agreed to provide the same advanced notice to the state attorney general before engaging in any non-reportable clinically integrated joint arrangements or risk-sharing joint arrangements. The settlement does not prevent CHI Franciscan from entering into such arrangements or transactions after the applicable notice and expiration period has lapsed.
  • Incentive and Quality Compensation: CHI Franciscan and TDC must amend their contracts to remove incentive compensation and quality bonus provisions for physicians.
  • Independent Contracting: CHI Franciscan is required to offer each commercial payor the option to negotiate price and other terms of physician payor contracts separately for TDC and CHI Franciscan physicians. CHI Franciscan is prohibited from conditioning any payor contract or the availability of certain terms for CHI Franciscan on reaching agreement with TDC physicians. The defendants also must implement firewall mechanisms to prevent the sharing of competitively sensitive contracting information.
  • Transfer of Assets: CHI Franciscan is required to divest an ambulatory surgery center that Franciscan acquired through its agreement with TDC. The state had alleged that after CHI Franciscan acquired the ambulatory surgery center, it began referring surgeries to another CHI Franciscan-owned medical center at a much higher cost.
  • Patient Notification: CHI Franciscan and TDC are required to inform patients of other independent competitive alternatives for laboratory and imaging services in the relevant geographic area.
  • Monetary Penalty: The defendants are required to pay a $2 million fine to the state. The state will use the funds to increase access to health care and the availability of health care services.

New Washington State Health Provider Transaction Reporting Statute

Presumably in response to the facts that gave rise to the CHI Franciscan physician practice merger challenge—namely that those transactions were not reportable under any federal or state pre-merger notification program in effect at the time—the Washington legislature passed a new law requiring certain in-state health care providers to provide at least 60-days’ notice of any material transaction to the state attorney general. The statute is effective July 28, 2019, and applies to transactions that are anticipated to be effective of close on or after January 1, 2020. The notice provision applies to mergers, acquisitions or contracting affiliations between two or more hospitals, hospital systems or provider organizations representing at least seven health care providers. “Health care provider” is broadly defined to include approximately 40 categories of licensed health care personnel, including physicians, nurses, chiropractors, podiatrists, optometrists, dentists and pharmacists. The notice must include the names and addresses of parties, a listing of all practice locations of both parties, a brief description of the nature and purpose of the transaction, and the anticipated closing/effective date of the transaction. For transactions reportable under the federal Hart-Scott-Rodino (HSR) Act, a copy of the HSR notification forms is to be provided in lieu of notice. The Washington attorney general has 30 days after notice is received to request additional information. The statute provides for civil penalties of up to $200 per day for failure to report.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© McDermott Will & Emery | Attorney Advertising

Written by:

McDermott Will & Emery

McDermott Will & Emery on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide

JD Supra Privacy Policy

Updated: May 25, 2018:

JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations.

This Privacy Policy describes how JD Supra, LLC ("JD Supra" or "we," "us," or "our") collects, uses and shares personal data collected from visitors to our website (located at (our "Website") who view only publicly-available content as well as subscribers to our services (such as our email digests or author tools)(our "Services"). By using our Website and registering for one of our Services, you are agreeing to the terms of this Privacy Policy.

Please note that if you subscribe to one of our Services, you can make choices about how we collect, use and share your information through our Privacy Center under the "My Account" dashboard (available if you are logged into your JD Supra account).

Collection of Information

Registration Information. When you register with JD Supra for our Website and Services, either as an author or as a subscriber, you will be asked to provide identifying information to create your JD Supra account ("Registration Data"), such as your:

  • Email
  • First Name
  • Last Name
  • Company Name
  • Company Industry
  • Title
  • Country

Other Information: We also collect other information you may voluntarily provide. This may include content you provide for publication. We may also receive your communications with others through our Website and Services (such as contacting an author through our Website) or communications directly with us (such as through email, feedback or other forms or social media). If you are a subscribed user, we will also collect your user preferences, such as the types of articles you would like to read.

Information from third parties (such as, from your employer or LinkedIn): We may also receive information about you from third party sources. For example, your employer may provide your information to us, such as in connection with an article submitted by your employer for publication. If you choose to use LinkedIn to subscribe to our Website and Services, we also collect information related to your LinkedIn account and profile.

Your interactions with our Website and Services: As is true of most websites, we gather certain information automatically. This information includes IP addresses, browser type, Internet service provider (ISP), referring/exit pages, operating system, date/time stamp and clickstream data. We use this information to analyze trends, to administer the Website and our Services, to improve the content and performance of our Website and Services, and to track users' movements around the site. We may also link this automatically-collected data to personal information, for example, to inform authors about who has read their articles. Some of this data is collected through information sent by your web browser. We also use cookies and other tracking technologies to collect this information. To learn more about cookies and other tracking technologies that JD Supra may use on our Website and Services please see our "Cookies Guide" page.

How do we use this information?

We use the information and data we collect principally in order to provide our Website and Services. More specifically, we may use your personal information to:

  • Operate our Website and Services and publish content;
  • Distribute content to you in accordance with your preferences as well as to provide other notifications to you (for example, updates about our policies and terms);
  • Measure readership and usage of the Website and Services;
  • Communicate with you regarding your questions and requests;
  • Authenticate users and to provide for the safety and security of our Website and Services;
  • Conduct research and similar activities to improve our Website and Services; and
  • Comply with our legal and regulatory responsibilities and to enforce our rights.

How is your information shared?

  • Content and other public information (such as an author profile) is shared on our Website and Services, including via email digests and social media feeds, and is accessible to the general public.
  • If you choose to use our Website and Services to communicate directly with a company or individual, such communication may be shared accordingly.
  • Readership information is provided to publishing law firms and authors of content to give them insight into their readership and to help them to improve their content.
  • Our Website may offer you the opportunity to share information through our Website, such as through Facebook's "Like" or Twitter's "Tweet" button. We offer this functionality to help generate interest in our Website and content and to permit you to recommend content to your contacts. You should be aware that sharing through such functionality may result in information being collected by the applicable social media network and possibly being made publicly available (for example, through a search engine). Any such information collection would be subject to such third party social media network's privacy policy.
  • Your information may also be shared to parties who support our business, such as professional advisors as well as web-hosting providers, analytics providers and other information technology providers.
  • Any court, governmental authority, law enforcement agency or other third party where we believe disclosure is necessary to comply with a legal or regulatory obligation, or otherwise to protect our rights, the rights of any third party or individuals' personal safety, or to detect, prevent, or otherwise address fraud, security or safety issues.
  • To our affiliated entities and in connection with the sale, assignment or other transfer of our company or our business.

How We Protect Your Information

JD Supra takes reasonable and appropriate precautions to insure that user information is protected from loss, misuse and unauthorized access, disclosure, alteration and destruction. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. You should keep in mind that no Internet transmission is ever 100% secure or error-free. Where you use log-in credentials (usernames, passwords) on our Website, please remember that it is your responsibility to safeguard them. If you believe that your log-in credentials have been compromised, please contact us at

Children's Information

Our Website and Services are not directed at children under the age of 16 and we do not knowingly collect personal information from children under the age of 16 through our Website and/or Services. If you have reason to believe that a child under the age of 16 has provided personal information to us, please contact us, and we will endeavor to delete that information from our databases.

Links to Other Websites

Our Website and Services may contain links to other websites. The operators of such other websites may collect information about you, including through cookies or other technologies. If you are using our Website or Services and click a link to another site, you will leave our Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We are not responsible for the data collection and use practices of such other sites. This Policy applies solely to the information collected in connection with your use of our Website and Services and does not apply to any practices conducted offline or in connection with any other websites.

Information for EU and Swiss Residents

JD Supra's principal place of business is in the United States. By subscribing to our website, you expressly consent to your information being processed in the United States.

  • Our Legal Basis for Processing: Generally, we rely on our legitimate interests in order to process your personal information. For example, we rely on this legal ground if we use your personal information to manage your Registration Data and administer our relationship with you; to deliver our Website and Services; understand and improve our Website and Services; report reader analytics to our authors; to personalize your experience on our Website and Services; and where necessary to protect or defend our or another's rights or property, or to detect, prevent, or otherwise address fraud, security, safety or privacy issues. Please see Article 6(1)(f) of the E.U. General Data Protection Regulation ("GDPR") In addition, there may be other situations where other grounds for processing may exist, such as where processing is a result of legal requirements (GDPR Article 6(1)(c)) or for reasons of public interest (GDPR Article 6(1)(e)). Please see the "Your Rights" section of this Privacy Policy immediately below for more information about how you may request that we limit or refrain from processing your personal information.
  • Your Rights
    • Right of Access/Portability: You can ask to review details about the information we hold about you and how that information has been used and disclosed. Note that we may request to verify your identification before fulfilling your request. You can also request that your personal information is provided to you in a commonly used electronic format so that you can share it with other organizations.
    • Right to Correct Information: You may ask that we make corrections to any information we hold, if you believe such correction to be necessary.
    • Right to Restrict Our Processing or Erasure of Information: You also have the right in certain circumstances to ask us to restrict processing of your personal information or to erase your personal information. Where you have consented to our use of your personal information, you can withdraw your consent at any time.

You can make a request to exercise any of these rights by emailing us at or by writing to us at:

Privacy Officer
JD Supra, LLC
10 Liberty Ship Way, Suite 300
Sausalito, California 94965

You can also manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard.

We will make all practical efforts to respect your wishes. There may be times, however, where we are not able to fulfill your request, for example, if applicable law prohibits our compliance. Please note that JD Supra does not use "automatic decision making" or "profiling" as those terms are defined in the GDPR.

  • Timeframe for retaining your personal information: We will retain your personal information in a form that identifies you only for as long as it serves the purpose(s) for which it was initially collected as stated in this Privacy Policy, or subsequently authorized. We may continue processing your personal information for longer periods, but only for the time and to the extent such processing reasonably serves the purposes of archiving in the public interest, journalism, literature and art, scientific or historical research and statistical analysis, and subject to the protection of this Privacy Policy. For example, if you are an author, your personal information may continue to be published in connection with your article indefinitely. When we have no ongoing legitimate business need to process your personal information, we will either delete or anonymize it, or, if this is not possible (for example, because your personal information has been stored in backup archives), then we will securely store your personal information and isolate it from any further processing until deletion is possible.
  • Onward Transfer to Third Parties: As noted in the "How We Share Your Data" Section above, JD Supra may share your information with third parties. When JD Supra discloses your personal information to third parties, we have ensured that such third parties have either certified under the EU-U.S. or Swiss Privacy Shield Framework and will process all personal data received from EU member states/Switzerland in reliance on the applicable Privacy Shield Framework or that they have been subjected to strict contractual provisions in their contract with us to guarantee an adequate level of data protection for your data.

California Privacy Rights

Pursuant to Section 1798.83 of the California Civil Code, our customers who are California residents have the right to request certain information regarding our disclosure of personal information to third parties for their direct marketing purposes.

You can make a request for this information by emailing us at or by writing to us at:

Privacy Officer
JD Supra, LLC
10 Liberty Ship Way, Suite 300
Sausalito, California 94965

Some browsers have incorporated a Do Not Track (DNT) feature. These features, when turned on, send a signal that you prefer that the website you are visiting not collect and use data regarding your online searching and browsing activities. As there is not yet a common understanding on how to interpret the DNT signal, we currently do not respond to DNT signals on our site.

Access/Correct/Update/Delete Personal Information

For non-EU/Swiss residents, if you would like to know what personal information we have about you, you can send an e-mail to We will be in contact with you (by mail or otherwise) to verify your identity and provide you the information you request. We will respond within 30 days to your request for access to your personal information. In some cases, we may not be able to remove your personal information, in which case we will let you know if we are unable to do so and why. If you would like to correct or update your personal information, you can manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard. If you would like to delete your account or remove your information from our Website and Services, send an e-mail to

Changes in Our Privacy Policy

We reserve the right to change this Privacy Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our Privacy Policy will become effective upon posting of the revised policy on the Website. By continuing to use our Website and Services following such changes, you will be deemed to have agreed to such changes.

Contacting JD Supra

If you have any questions about this Privacy Policy, the practices of this site, your dealings with our Website or Services, or if you would like to change any of the information you have provided to us, please contact us at:

JD Supra Cookie Guide

As with many websites, JD Supra's website (located at (our "Website") and our services (such as our email article digests)(our "Services") use a standard technology called a "cookie" and other similar technologies (such as, pixels and web beacons), which are small data files that are transferred to your computer when you use our Website and Services. These technologies automatically identify your browser whenever you interact with our Website and Services.

How We Use Cookies and Other Tracking Technologies

We use cookies and other tracking technologies to:

  1. Improve the user experience on our Website and Services;
  2. Store the authorization token that users receive when they login to the private areas of our Website. This token is specific to a user's login session and requires a valid username and password to obtain. It is required to access the user's profile information, subscriptions, and analytics;
  3. Track anonymous site usage; and
  4. Permit connectivity with social media networks to permit content sharing.

There are different types of cookies and other technologies used our Website, notably:

  • "Session cookies" - These cookies only last as long as your online session, and disappear from your computer or device when you close your browser (like Internet Explorer, Google Chrome or Safari).
  • "Persistent cookies" - These cookies stay on your computer or device after your browser has been closed and last for a time specified in the cookie. We use persistent cookies when we need to know who you are for more than one browsing session. For example, we use them to remember your preferences for the next time you visit.
  • "Web Beacons/Pixels" - Some of our web pages and emails may also contain small electronic images known as web beacons, clear GIFs or single-pixel GIFs. These images are placed on a web page or email and typically work in conjunction with cookies to collect data. We use these images to identify our users and user behavior, such as counting the number of users who have visited a web page or acted upon one of our email digests.

JD Supra Cookies. We place our own cookies on your computer to track certain information about you while you are using our Website and Services. For example, we place a session cookie on your computer each time you visit our Website. We use these cookies to allow you to log-in to your subscriber account. In addition, through these cookies we are able to collect information about how you use the Website, including what browser you may be using, your IP address, and the URL address you came from upon visiting our Website and the URL you next visit (even if those URLs are not on our Website). We also utilize email web beacons to monitor whether our emails are being delivered and read. We also use these tools to help deliver reader analytics to our authors to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

Analytics/Performance Cookies. JD Supra also uses the following analytic tools to help us analyze the performance of our Website and Services as well as how visitors use our Website and Services:

  • HubSpot - For more information about HubSpot cookies, please visit
  • New Relic - For more information on New Relic cookies, please visit
  • Google Analytics - For more information on Google Analytics cookies, visit To opt-out of being tracked by Google Analytics across all websites visit This will allow you to download and install a Google Analytics cookie-free web browser.

Facebook, Twitter and other Social Network Cookies. Our content pages allow you to share content appearing on our Website and Services to your social media accounts through the "Like," "Tweet," or similar buttons displayed on such pages. To accomplish this Service, we embed code that such third party social networks provide and that we do not control. These buttons know that you are logged in to your social network account and therefore such social networks could also know that you are viewing the JD Supra Website.

Controlling and Deleting Cookies

If you would like to change how a browser uses cookies, including blocking or deleting cookies from the JD Supra Website and Services you can do so by changing the settings in your web browser. To control cookies, most browsers allow you to either accept or reject all cookies, only accept certain types of cookies, or prompt you every time a site wishes to save a cookie. It's also easy to delete cookies that are already saved on your device by a browser.

The processes for controlling and deleting cookies vary depending on which browser you use. To find out how to do so with a particular browser, you can use your browser's "Help" function or alternatively, you can visit which explains, step-by-step, how to control and delete cookies in most browsers.

Updates to This Policy

We may update this cookie policy and our Privacy Policy from time-to-time, particularly as technology changes. You can always check this page for the latest version. We may also notify you of changes to our privacy policy by email.

Contacting JD Supra

If you have any questions about how we use cookies and other tracking technologies, please contact us at:

- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.